[An Experimental Study of the Therapeutic Effect of Interleukin-2 and Interleukin-12 with and Without Amphotericin B on Pulmonary Fungal Infection].

Chang-ran Zhang,Ying-chun Tang,K Kawakami,Tian-tuo Zhang,Kou-xing Zhang,Jia-xin Zhu
DOI: https://doi.org/10.3760/j:issn:1001-0939.2004.04.005
2004-01-01
Abstract:OBJECTIVE To study the therapeutic effect of interleukin-2 (IL-2) and interleukin-12 (IL-12) with and without amphotericin B on pulmonary fungal infection of mice. METHODS A mouse model of pulmonary invasive aspergillus fumigatus (IPA) infection was established and the mice were divided into different groups, treated with IL-2 and IL-12 with and without amphotericin B. The survival number of mice in 15 days and the colony count of lung tissue in the different groups were observed. RESULTS IL-2, IL-12 and amphotericin B showed synergistic effect in prolonging the survival of the infected mice and reducing the colony count in the lung tissue. CONCLUSION IL-2 and IL-12 are effective adjuvant therapeutic agents in the immunosuppressed hosts.
What problem does this paper attempt to address?